The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    Yates, Jason Derick
    Director born in June 1973
    Individual (20 offsprings)
    Officer
    2023-09-22 ~ now
    OF - Director → CIF 0
  • 2
    Pritchard, Ian
    Director born in December 1969
    Individual (23 offsprings)
    Officer
    2023-09-22 ~ now
    OF - Director → CIF 0
  • 3
    Falzon, Carl
    Director born in June 1977
    Individual (2 offsprings)
    Officer
    2023-09-22 ~ now
    OF - Director → CIF 0
  • 4
    C.S.T. PHARMA GROUP HOLDINGS LIMITED - now
    ST TOPCO (UK) LIMITED - 2019-11-06
    Unit 5-7, Tintagel Way, Aldridge, Walsall, England
    Active Corporate (4 parents, 7 offsprings)
    Profit/Loss (Company account)
    911,544 GBP2023-05-01 ~ 2024-04-30
    Person with significant control
    2023-09-22 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
parent relation
Company in focus

CURAGENIX LIFE SCIENCES LIMITED

Standard Industrial Classification
46460 - Wholesale Of Pharmaceutical Goods
Brief company account
Intangible Assets
182,627 GBP2024-09-30
Debtors
3,808 GBP2024-09-30
Creditors
Current, Amounts falling due within one year
-186,335 GBP2024-09-30
Net Current Assets/Liabilities
-182,527 GBP2024-09-30
Total Assets Less Current Liabilities
100 GBP2024-09-30
Equity
Called up share capital
100 GBP2024-09-30
Average Number of Employees
02023-09-22 ~ 2024-09-30
Intangible Assets - Gross Cost
Computer software
1,350 GBP2024-09-30
0 GBP2023-09-21
Patents/Trademarks/Licences/Concessions
181,277 GBP2024-09-30
0 GBP2023-09-21
Intangible Assets - Gross Cost
182,627 GBP2024-09-30
0 GBP2023-09-21
Intangible Assets - Accumulated Amortisation & Impairment
Patents/Trademarks/Licences/Concessions
0 GBP2023-09-21
Intangible Assets - Accumulated Amortisation & Impairment
0 GBP2023-09-21
Intangible Assets
Patents/Trademarks/Licences/Concessions
181,277 GBP2024-09-30
Other Debtors
Amounts falling due within one year
3,808 GBP2024-09-30
Trade Creditors/Trade Payables
Current
55,555 GBP2024-09-30
Amounts owed to group undertakings
Current
130,780 GBP2024-09-30
Creditors
Current
186,335 GBP2024-09-30

  • CURAGENIX LIFE SCIENCES LIMITED
    Info
    Registered number 15157235
    Unit 5-7 Tintagel Way, Aldridge, Walsall WS9 8ER
    Private Limited Company incorporated on 2023-09-22 (1 year 9 months). The company status is Active.
    The last date of confirmation statement was made at 2024-09-21
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.